Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders

被引:388
作者
Andrews, G
Issakidis, C
Sanderson, K
Corry, J
Lapsley, H
机构
[1] Univ New S Wales, St Vincents Hosp, Sch Psychiat, Hlth Org Collaborating Ctr Mental Hlth Policy, Sydney, NSW, Australia
[2] Univ New S Wales, St Vincents Hosp, Sch Psychiat, Policy & Epidemiol Grp, Sydney, NSW, Australia
[3] Univ Queensland, Sch Publ Hlth, Ctr Hlth Res, Brisbane, Qld, Australia
关键词
D O I
10.1192/bjp.184.6.526
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Mental health survey data are now being used proactively to decide how the burden of disease might best be reduced. Aims To study the cost-effectiveness of current and optimal treatments for mental disorders and the proportion of burden avertable by each. Method Data for three affective, four anxiety and two alcohol use disorders and for schizophrenia were compared in terms of cost, burden averted and efficiency of current and optimal treatment. We then calculated the burden unavertable given current knowledge. The unit of health gain was a reduction in the years lived with disability (YLDs). Results Summing across all disorders, current treatment averted 13% of the burden, at an average cost of AUS$30 000 per YLD gained. Optimal treatment at current coverage could avert 20% of the burden, at an average cost of AUS$18 000 per YLD gained. Optimal treatment at optimal coverage could avert 28% of the burden, at AUS$16 000 per YLD gained. Sixty per cent of the burden of mental disorders was deemed to be unavertable. Conclusions The efficiency of treatment varied more than tenfold across disorders. Although coverage of some of the more efficient treatments should be extended, other factors justify continued use of less-efficient treatments for some disorders. Declaration of interest None. Funding detailed in Acknowledgements.
引用
收藏
页码:526 / 533
页数:8
相关论文
共 37 条
[1]  
ANDREWS G, 1985, ARCH GEN PSYCHIAT, V42, P537
[2]   Cost-effectiveness of current and optimal treatment for schizophrenia [J].
Andrews, G ;
Sanderson, K ;
Corry, J ;
Issakidis, C ;
Lapsley, H .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 183 :427-435
[3]   Deconstructing current comorbidity: data from the Australian National Survey of Mental Health and Well-Being [J].
Andrews, G ;
Slade, T ;
Issakidis, C .
BRITISH JOURNAL OF PSYCHIATRY, 2002, 181 :306-314
[4]   Randomised controlled trials in psychiatry: important but poorly accepted [J].
Andrews, G .
BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7209) :562-564
[5]   Prevalence, comorbidity, disability and service utilisation - Overview of the Australian National Mental Health Survey [J].
Andrews, G ;
Henderson, S ;
Hall, W .
BRITISH JOURNAL OF PSYCHIATRY, 2001, 178 :145-153
[6]  
ANDREWS G, 2003, TREATMENT ANXIETY DI
[7]  
Andrews G, 2003, AUSTRALAS PSYCHIATRY, V11, P29
[8]  
Andrews Gavin, 2000, J Ment Health Policy Econ, V3, P175, DOI 10.1002/mhp.96
[9]  
[Anonymous], 2003, AUSTRALAS PSYCHIATRY
[10]  
[Anonymous], EFFECTIVE TREATMENT